# Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/subcutaneous-tanezumab-for-osteoarthritis-of-the-hip-or-knee-efficacy-and-safety/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Françis Berenbaum,Francisco J. Blanco,Ali Guermazi,Kenji Miki,Takaharu Yamabe,Lars Viktrup,Rod Junor,William Carey,Mark T. Brown,Christine R. West,Kenneth M. Verburg |
| Citations | 169 |
| DOI | 10.1136/annrheumdis-2019-216296 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ard.bmj.com/content/annrheumdis/79/6/800.full.pdf |
| OpenAlex ID | https://openalex.org/W3014194256 |
| PMID | 32234715 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Lars Viktrup](https://scholariq.org/researchers/lars-viktrup/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Osteoarthritis Treatment and Mechanisms](https://scholariq.org/topics/osteoarthritis-treatment-and-mechanisms/)

## Paper topics

- [Osteoarthritis Treatment and Mechanisms](https://scholariq.org/topics/osteoarthritis-treatment-and-mechanisms/)
- [Pain Mechanisms and Treatments](https://scholariq.org/topics/pain-mechanisms-and-treatments/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.